The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
The Mighty Mitochondria: Revisiting the Cell's Workhorse in Adipose Tissue
November 15th 2014New evidence indicates that mitochondria are a crucial element in metabolic homeostasis in white adipocytes. They appear to have significant involvement in adipogenesis, fatty acid synthesis and esterification, branched-chain amino acid catabolism, and lipolysis
Understanding ANCA-Associated Vasculitis
Affecting just one in every 100,000 people, ANCA-associated vasculitis is not one of the more common conditions nephrologists will encounter. However, without proper treatment it can have serious adverse effects on a patient's life.
A New Approach to Infection: Vitamin D
November 12th 2014Vitamin D has a role in the immune system distinct from its regulatory role in calcium homeostasis. Immune cells express the vitamin D receptor and can metabolize circulating 25-hydroxyvitamin D into its active form, 1,25-dihydroxyvitamin D. This finding has researchers looking for new ways to manipulate vitamin D in the innate and adaptive immune systems.
Diabetes & Low T: Treat Testosterone Deficiency?
November 12th 2014Low testosterone is a common condition among men with diabetes-diabetic men are approximately twice as likely as others to develop low testosterone and hypogonadism. Because its symptoms mimic other conditions, patients often fail to report concerns and clinicians may fail to diagnose "Low T."
Traditional Dieting, Alternate Day Fasting Similar For Weight Loss in Head-to-Head Trial
November 9th 2014A small but rigorous 6-month randomized, controlled parallel arm trial comparing alternate day fasting and daily calorie restriction showed that each approach can result in significant weight loss for individuals who are overweight or have obesity, with similar adherence between the two methods of dieting.
Less Medication, Better Glycemic Control Seen in Low Saturated Fat Diet for Type 2 Diabetes
November 9th 2014For individuals with type 2 diabetes mellitus, a low carbohydrate, low saturated fat diet in combination with exercise resulted in superior glycemic control with less medication use than did a higher carbohydrate diet
Algorithms Not Sole Factor in Prescribing for Obese Patients
November 6th 2014There is currently no algorithm to guide clinicians in deciding which medication to choose to help promote weight loss in individuals with obesity. Rather, clinicians must take stock of a variety of factors when making treatment decisions for a particular patient.
New Device Beats Placebo, Produces Durable Results in Moderately Obese Patients
November 6th 2014An intragastric dual-balloon device was well tolerated and proved effective for patients with moderate levels of obesity, owing in part to its ability to conform to stomach anatomy, according to Jaime Ponce, MD, Medical Director for the Bariatric Surgery program at Hamilton Medical Center, in Dalton, Georgia.
Bridging the Gap Between Provider Offerings and Patient Understanding
Even as Electronic Health Record (EHR) systems become more commonplace in the medical community there is still a large knowledge gap between health care professionals and their patients regarding the availability and use of these systems, according to a recent survey.
The Burden of Disease in Homozygous Familial Hypercholesterolemia
November 4th 2014Homozygous familial hypercholesterolemia (HoFH) is a rare and severe hereditary lipid disorder. Patients with HoFH generally have very high serum levels of low-density lipoprotein cholesterol (LDL-C) that is treatment-resistant. HoFH puts affected patients at extremely high risk of premature onset coronary heart disease, and many patients die before they reach their mid-30s.
Bariatric Surgery: Bypass, Band, or Sleeve at 2 Years
November 4th 2014As the number of bariatric surgeries increase, clinicians require more and better data about its long-term outcomes. As we know, as more people take a medication or undergo a surgical procedure, the better the quality of the collective data. It's the strength in numbers concept. In the case of bariatric surgery, many clinicians have questions about treatment failure rates and they suspect that reports of sustained weight loss may be overly optimistic.
Defining Treatment Options for Obese Asthmatic Patients
Looking at patients with asthma it can be easy to group them all together for treatment options. Recent studies have shown that that may not be the best way to approach helping people dealing with both obesity and asthma.
Aging Associated with Defects in Beta Cell Ca2+ Dynamics
A group of international researchers led by Luosheng Li, MD, of the Rolf Luft Research Center for Diabetes and Endocrinology at the Karolinska Institutet, Karolinska University Hospital in Stockholm, Sweden, recently demonstrated that age-dependent decline in insulin secretion (and thus glucose homeostasis) from the beta cell in experimental mice models is associated with subtle changes in Ca2+ dynamics.
New Developments in Insulin Therapy for Type 2 Diabetes
In the American Journal of Medicine, Christopher Sorli, MD, of the Billings Clinic in Montana, reviewed new developments in insulin therapy for type 2 diabetes. He explained that insulin initiation often involved basal-only therapy in conjunction with existing oral glucose-lowering drugs.